What APOE4 changes—and what it doesn’t
APOE is a gene that helps make a protein involved in moving fats, including cholesterol, through the body and brain. The APOE4 version is associated with a higher chance of developing Alzheimer’s disease than some other versions. Having two copies, as Hemsworth disclosed, is a stronger risk marker than having one—but it still cannot say whether or when an individual will develop the disease.
That distinction matters because genes influence probabilities, not fixed outcomes. A risk result is not evidence that Alzheimer’s is already present, and it cannot provide a personal forecast on its own.
Why food advice may come with the result
A dietary warning in this context is a precaution, not a treatment for the gene. APOE4 is also linked to differences in how the body handles fats, so a clinician may discuss food choices that support healthy cholesterol and cardiovascular health. That can include limiting foods high in saturated fat, depending on a person’s overall health and circumstances.
The reasoning is about managing factors that may be relevant to health—not changing the inherited APOE version. Diet does not remove the gene or guarantee protection from Alzheimer’s. Nor does the genetic result, by itself, establish one specific diet as the right choice for everyone; personal advice belongs in a conversation with a qualified health professional.
A risk marker, not a verdict
The practical consequence is a reason to take health guidance seriously without treating a genetic test as a diagnosis. The distinction is easy to lose in a headline: a result can make risk more salient, while leaving the individual future uncertain.
